6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Vishay Intertechnology Reports First Quarter 2026 Results
Just now	Local Bounti Announces First Quarter 2026 Financial Results
Just now	Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026
Just now	Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update
1m ago	Gilat Reports First Quarter 2026 Results

About

5.41USD-1.43 -20.91%

Closed • Updated at 11:44 GMT+00:00

Market Cap$24.19M

Volume53.2K

Beta2.47

RSI40.94

Gross Margin54.11%

Health TechnologyMedical Specialties

Harvard Bioscience, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Harvard Bioscience Announces First Quarter 2026 Financial Results

Harvard Bioscience to Participate in Upcoming Investor Conferences

Harvard Bioscience Schedules First Quarter 2026 Earnings Conference Call for May 12, 2026 at 8:00 AM ET

Harvard Bioscience Announces Fourth Quarter and Full-Year 2025 Financial Results

Harvard Bioscience Announces Reverse Stock Split

Recent Videos

Next-Generation Implantable Telemetry for Cardiometabolic, Neuro, and Infectious Disease Research

Next-Generation Implantable Telemetry for Cardiometabolic, Neuro, and Infectious Disease Research

Feb 03, 2026

My Insight on Harvard Bioscience's Big Loan & Board Seat

My Insight on Harvard Bioscience's Big Loan & Board Seat

Dec 22, 2025

Harvard Bioscience Q3 2025: Revenue Beat, EPS Miss & Turnaround Hopes

Harvard Bioscience Q3 2025: Revenue Beat, EPS Miss & Turnaround Hopes

Dec 07, 2025

Harvard Bioscience Q3 2025: Margin Gains vs Debt Risks Explained

Harvard Bioscience Q3 2025: Margin Gains vs Debt Risks Explained

Dec 07, 2025

Community Chat

Ask AI